Crixivan (indinavir sulfate) / Merck (MSD) 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Crixivan (indinavir sulfate) / Merck (MSD)
2014-002830-30: Supersaturation and precipitation of indinavir in the stomach of healthy human volunteers Supersaturatie en precipitatie van indinavir in de maag van gezonde vrijwilligers

Ongoing
4
10
Europe
Crixivan, Nexiam, J05AE02, CRIXIVAN® 400 mg hard capsules, Nexiam 40mg maagsapresistente tabletten, CRIXIVAN® 400 mg hard capsules, Nexiam 40mg maagsapresistente tabletten
KU Leuven - Drug Delivery & Disposition, KU Leuven
Healthy human volunteers(administration of a Protease inhibitor) Gezonde vrijwilligers (toediening van een Protease inhibitor)
 
 
2004-000441-38: Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)

 
3/4
2
Europe
NA, NA, INVIRASE*270 CPS 200 MG, NORVIR*336 CPS MOLLI 100 MG, CRIXIVAN*180 CPS 400 MG, VIRACEPT*270 CPR 250 MG, FORTOVASE*180 CPS 200 MG, AGENERASE*240 CPS 150 MG, KALETRA*180 CPS BLISTER, VIRAMUNE*60 CPR 200 MG, SUSTIVA*90 CPS 200 MG, RETROVIR* 28 CPR 300 MG, VIDEX 400*30 CPS 400 MG, HIVID 0,750*100 CPR 0,750 MG, ZERIT 40*56 CPS 40 MG, EPIVIR*60 CPR 150 MG, COMBIVIR*60CPR BL 150/300MG, ZIAGEN*60 CPR RIV. 300 MG, TRIZIVIR*60 CPR RIV. BLISTER, VIREAD*30 CPR 245 MG, FUZEON*90MG/ML 60FL+60FL+60S
National Institute of Allergy and Infectious Diseases, National Institutes of Health, COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDS
HIV infection
 
 

Download Options